Codon-specific translation reprogramming promotes resistance to targeted therapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Codon-specific translation reprogramming promotes resistance to targeted therapy
Authors
Keywords
-
Journal
NATURE
Volume 558, Issue 7711, Pages 605-609
Publisher
Springer Nature
Online
2018-06-19
DOI
10.1038/s41586-018-0243-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Elp3 links tRNA modification to IRES-dependent translation of LEF1 to sustain metastasis in breast cancer
- (2016) Sylvain Delaunay et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Progenitor potential of nkx6.1-expressing cells throughout zebrafish life and during beta cell regeneration
- (2015) Aurélie P. Ghaye et al. BMC BIOLOGY
- Optimization of Codon Translation Rates via tRNA Modifications Maintains Proteome Integrity
- (2015) Danny D. Nedialkova et al. CELL
- A Dynamic Unfolded Protein Response Contributes to the Control of Cortical Neurogenesis
- (2015) Sophie Laguesse et al. DEVELOPMENTAL CELL
- Vemurafenib resistance reprograms melanoma cells towards glutamine dependence
- (2015) Jenny E Hernandez-Davies et al. Journal of Translational Medicine
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state
- (2015) Annelien Verfaillie et al. Nature Communications
- Phosphorylation of Elp1 by Hrr25 Is Required for Elongator-Dependent tRNA Modification in Yeast
- (2015) Wael Abdel-Fattah et al. PLoS Genetics
- HTSeq--a Python framework to work with high-throughput sequencing data
- (2014) S. Anders et al. BIOINFORMATICS
- Archaeal Elp3 catalyzes tRNA wobble uridine modification at C5 via a radical mechanism
- (2014) Kiruthika Selvadurai et al. Nature Chemical Biology
- Cell type–specific mRNA purification by translating ribosome affinity purification (TRAP)
- (2014) Myriam Heiman et al. Nature Protocols
- Response of BRAF-Mutant Melanoma to BRAF Inhibition Is Mediated by a Network of Transcriptional Regulators of Glycolysis
- (2014) T. J. Parmenter et al. Cancer Discovery
- A melanocyte lineage program confers resistance to MAP kinase pathway inhibition
- (2013) Cory M. Johannessen et al. NATURE
- Bortezomib antagonizes microtubule-interfering drug-induced apoptosis by inhibiting G2/M transition and MCL-1 degradation
- (2013) F Rapino et al. Cell Death & Disease
- Loss of a Conserved tRNA Anticodon Modification Perturbs Cellular Signaling
- (2013) Boris Zinshteyn et al. PLoS Genetics
- Biosynthesis and Function of Posttranscriptional Modifications of Transfer RNAs
- (2012) Basma El Yacoubi et al. Annual Review of Genetics
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib
- (2012) Jeffrey A. Sosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Speeding with control: codon usage, tRNAs, and ribosomes
- (2012) Eva Maria Novoa et al. TRENDS IN GENETICS
- Activation of mTORC2 by Association with the Ribosome
- (2011) Vittoria Zinzalla et al. CELL
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- Elongator Controls the Migration and Differentiation of Cortical Neurons through Acetylation of α-Tubulin
- (2009) Catherine Creppe et al. CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More